Skip to search formSkip to main contentSkip to account menu

turoctocog alfa

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Factor VIIIrecombinant factor VIII N8

Narrower (1)

Novoeight

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A
Factor VIII (FVIII) is indicated for the prevention or treatment of bleeding in patients with hemophilia A. FVIII product… 
2016
2016
Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8‐GP
Essentials Chromogenic assays may be less variable than one‐stage clot assays for measuring modified factor VIII. Chromogenic… 
Review
2015
Review
2015
The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A
Turoctocog alfa (NovoEight®) is a human recombinant coagulation factor VIII (rFVIII) for the treatment of patients with… 
Review
2015
Review
2015
Turoctocog alfa (recombinant factor VIII)
Summary Turoctocog alfa (NovoEight®) is a new recombinant factor VIII (rFVIII) with a truncated B domain and a high degree of… 
2014
2014
Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa
Haemophilia and its treatment interfere with patients' life, so health‐related quality of life (HRQoL) should be assessed when… 
2014
2014
Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials
Recombinant factor VIII (rFVIII) products provide a safe and efficacious replacement therapy for prevention and treatment of… 
Review
2014
Review
2014
Turoctocog Alfa for the Treatment of Hemophilia A
Hemophilia A (HA) represents one of the most common genetic bleeding disorders worldwide and results from a deficiency in factor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)